AMD

Landolt C Testing Reveals Lower Pursuit Gains for Those with AMD

This impairment likely further compromises their dynamic VA and thus ability to view moving targets.
06/27/2024

Standing Test Reveals Impaired Hemodynamic Effects in AMD

The result of the first 20 seconds could be associated with the pathophysiology of the disease's progression.
06/20/2024

AMD Staging: More Than Wet Vs. Dry

Various imaging biomarkers can help you get a truer sense of disease status and predict a patient’s risk of progression. Here’s what to look out for.
06/15/2024

Melatonin Shown to Decrease Risk of AMD Development and Progression

Researchers acknowledged that lifestyle changes may have also contributed, but nevertheless speculated that the drug may reduce oxidative stress and subsequent VEGF overexpression.
06/10/2024

Personalized Wet AMD Management with At-Home OCT Possible

While from a small study of 27 eyes, recent findings showed an almost 50% reduction in treatment burden while maintaining stable visual acuity.
05/28/2024

Low-dose Aspirin Not Effective in Preventing AMD

The regimen also wasn’t helpful in slowing or preventing progression of the disease.
05/24/2024

High-dose Aflibercept Pushes Dosing Interval to Five Months

Nearly half of subjects went 20 weeks or longer between injections with the 8mg formulation. The regimen also maintained BCVA gains out to 96 weeks.
05/13/2024

PED Lesions, Hyperreflective Foci Associated With Visual Decline in Dry AMD

Mesopic dysfunction was found following previous predominant rod-mediated function loss, whereas the overall highest functional loss was detected with development of cRORA lesions.
05/03/2024

Meta-analysis Associates Three Air Pollutants with AMD Risk

The relationship was not causal, suggesting that more research is needed to elucidate the underlying mechanisms.
05/03/2024

Study: Blue-Light IOLs Can Reduce Progression of Macular Atrophy, But Not Incidence

Following cataract surgery, the pathology developed in 23% of eyes with filtering lens implants and 19% without. Mean annual increases, however, were 0.78mm2 and 1.26mm2, respectively.
05/02/2024

Upcoming Events

August 14, 2024

The 3 I's of Geographic Atrophy: Imaging, Identification, and Intervention
Location: Virtual
Presenters:  Mark Dunbar, OD, FAAO, and David Chin Yee, MD
Webinar: 8:30pm ET


Sponsored by Apellis

Register here

September 8, 2024

Ocular Surface Symposium
Location: Renaissance Chicago Downtown Hotel
Presenter:  Paul Karpecki, OD

Register here

September 9, 2024

The 3 I's of Geographic Atrophy: Imaging, Identification, and Intervention
Location: Virtual
Presenters:  Damon Dierker, OD, FAAO, and Lucas Lindsell, OD, MD
Webinar: 8:30pm ET


Sponsored by Apellis

Register here